Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hutton

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|September 4, 2022
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registryRoland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Infectious Diseases of Poverty|October 11, 2022
Impact of the national hepatitis B immunization program in China: a modeling studyZhixi Liu, Mengying Li, David W Hutton, et al.
Drug and Alcohol Dependence|August 5, 2025
Understanding risk and protective factors associated with opioid misuse among at-risk adolescents and young adults in the emergency departmentErin E Bonar, Meredith Kotov, Carrie Bourque, et al.
Pediatrics|November 25, 2024
Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young ChildrenDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
Stem Cell Reports|October 1, 2021
Assessing patient perception of risk in ocular stem cell therapiesPeter Y Zhao, Sunjong Ji, Paula Anne Newman-Casey, et al.
Pediatrics|November 25, 2024
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus IllnessDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
Vaccine|September 6, 2024
Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virusDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
MMWR. Morbidity and Mortality Weekly Report|August 15, 2024
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024Amadea Britton, Lauren E Roper, Camille N Kotton, et al.
Circulation. Arrhythmia and Electrophysiology|June 17, 2016
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAILJames V Freeman, David W Hutton, Geoffrey D Barnes, et al.
Vaccine|March 20, 2021
Cost-effectiveness of pediatric norovirus vaccination in daycare settingsLauren N Steimle, Joshua Havumaki, Marisa C Eisenberg, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
European Heart Journal. Quality of Care & Clinical Outcomes|September 4, 2022
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registryRoland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Infectious Diseases of Poverty|October 11, 2022
Impact of the national hepatitis B immunization program in China: a modeling studyZhixi Liu, Mengying Li, David W Hutton, et al.
Drug and Alcohol Dependence|August 5, 2025
Understanding risk and protective factors associated with opioid misuse among at-risk adolescents and young adults in the emergency departmentErin E Bonar, Meredith Kotov, Carrie Bourque, et al.
Pediatrics|November 25, 2024
Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young ChildrenDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
Stem Cell Reports|October 1, 2021
Assessing patient perception of risk in ocular stem cell therapiesPeter Y Zhao, Sunjong Ji, Paula Anne Newman-Casey, et al.
Pediatrics|November 25, 2024
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus IllnessDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
Vaccine|September 6, 2024
Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virusDavid W Hutton, Lisa A Prosser, Angela M Rose, et al.
MMWR. Morbidity and Mortality Weekly Report|August 15, 2024
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024Amadea Britton, Lauren E Roper, Camille N Kotton, et al.
Circulation. Arrhythmia and Electrophysiology|June 17, 2016
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAILJames V Freeman, David W Hutton, Geoffrey D Barnes, et al.
Vaccine|March 20, 2021
Cost-effectiveness of pediatric norovirus vaccination in daycare settingsLauren N Steimle, Joshua Havumaki, Marisa C Eisenberg, et al.
Pageof 11